Sánchez-Fernández Cristina, González Carmen, Mercer Linda D, Beart Philip M, Ruiz-Gayo Mariano, Fernández-Alfonso María S
Departamento de Farmacologia, Universidad Complutense, Madrid, Spain.
J Cereb Blood Flow Metab. 2003 Mar;23(3):364-70. doi: 10.1097/01.WCB.0000043948.67811.8F.
The authors report that cholecystokinin (CCK), via its subtype 2 receptor (CCK2R) located presynaptically on cerebral arteries, mediates the release of nitric oxide (NO), which induces vasodilatation. Whereas CCK octapeptide and its fragment CCK tetrapeptide (CCK-4) lack a direct effect on the smooth muscle of pial vessels, the authors showed that both CCK peptides modulate the neurogenic responses in bovine cerebral arteries. The neurogenic vasodilatation induced by CCK-4 was blocked by the CCK2R antagonist, L-365,260, and antagonized by neuronal NO synthase (nNOS) inhibitors, but was independent of the endothelium. In whole-mount arteries, CCK2Rs were detected in nerve fibers and colocalized with nNOS and synaptophysin. The findings provide, for the first time, a neural mechanism by which CCK may increase cerebral blood flow.
作者报告称,胆囊收缩素(CCK)通过其位于脑动脉突触前的2型受体(CCK2R)介导一氧化氮(NO)的释放,从而诱导血管舒张。虽然CCK八肽及其片段CCK四肽(CCK-4)对软脑膜血管的平滑肌没有直接作用,但作者表明这两种CCK肽都能调节牛脑动脉的神经源性反应。CCK-4诱导的神经源性血管舒张被CCK2R拮抗剂L-365,260阻断,并被神经元型一氧化氮合酶(nNOS)抑制剂拮抗,但与内皮无关。在整装动脉中,CCK2R在神经纤维中被检测到,并与nNOS和突触素共定位。这些发现首次提供了一种CCK可能增加脑血流量的神经机制。